JP Morgan Chase’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96K Hold
100
﹤0.01% 7018
2025
Q4
$2.84K Buy
+100
New +$2.71K ﹤0.01% 6889
2023
Q2
Sell
-133
Closed -$6.72K 6971
2023
Q1
$6.72K Hold
133
﹤0.01% 6201
2022
Q4
$8K Buy
+133
New +$10.3K ﹤0.01% 6071

Other funds holding CNBS

JP Morgan Chase's CNBS Position: Q1 2026 in Review

JP Morgan Chase held its Amplify Seymour Cannabis ETF (CNBS) position steady in Q1 2026 at 100 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #7018.

JP Morgan Chase first reported a position in CNBS in Q4 2022 and has held it in 4 quarters since. The position peaked at $8K in Q4 2022. 20 funds tracked by Wall St. Rank hold CNBS as of Q1 2026.

  • JP Morgan Chase held 100 shares of Amplify Seymour Cannabis ETF worth $1.96K as of Q1 2026.
  • JP Morgan Chase left its Amplify Seymour Cannabis ETF share count unchanged in Q1 2026.
  • Amplify Seymour Cannabis ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7018 holding.
  • JP Morgan Chase first reported a position in Amplify Seymour Cannabis ETF in Q4 2022 and has held it in 4 quarters since.
  • JP Morgan Chase's Amplify Seymour Cannabis ETF position peaked at $8K in Q4 2022.
  • 20 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.